BlackRock Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
BIT
BFA
BlackRock Investment Management's ABBV Position: Q4 2016 in Review
BlackRock Investment Management increased its AbbVie (ABBV) stake by 4.6% in Q4 2016, buying an estimated $10.9M and bringing the position to 4,053,124 shares worth $254M. The position accounts for 0.29% of the portfolio, ranked #68.
BlackRock Investment Management first reported a position in ABBV in Q2 2013 and has held it in 15 quarters since. The position peaked at $642M in Q2 2015. 1,691 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.
- BlackRock Investment Management held 4,053,124 shares of AbbVie worth $254M as of Q4 2016.
- BlackRock Investment Management bought 178,702 AbbVie shares in Q4 2016, an estimated $10.9M.
- AbbVie made up 0.29% of BlackRock Investment Management's portfolio in Q4 2016, its #68 holding.
- BlackRock Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 15 quarters since.
- BlackRock Investment Management's AbbVie position peaked at $642M in Q2 2015.
- 1,691 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.
Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.